ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,680, issued on July 15, was assigned to Albert-Ludwigs-Universitat Freiburg (Freiburg, Germany).
"Inhibition of histone methyl transferases to treat cancer" was invented by Roland Schule (Weisweil, Germany), Eric Metzger (Algolsheim, France), Sheng Wang (Freiburg, Germany), Manfred Jung (Gundelfingen, Germany), Nicolas Barthes (Blodelsheim, France), Bernhard Breit (Gundelfingen, Germany), Daad Sarraf (Freiburg, Germany) and Tabea Pappert (Harxheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is inter alia concerned with an inhibitor selected from the group consisting of a selective KMT9-inhibitor, a selective METTL21...